Related Experiment Video
Updated: Jul 18, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Melanocortin-3 receptor activates MAP kinase via PI3 kinase
Biaoxin Chai1, Ji-Yao Li, Weizhen Zhang
1Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Abstract:
HEK 293 cells stably expressing human melanocortin-3 receptor (MC3R) were exposed to melanocortin receptor agonist, NDP-MSH (10(-)(10)-10(-)(6) M). ERK1/2 was phosphorylated in a dose-dependent manner with an EC(50) of 3.3+/-1.5 x 10(-)(9) M, similar to the IC(50) of NDP-MSH binding to the MC3R. ERK1/2 phosphorylation was blocked by the melanocortin receptor antagonists SHU9119. NDP-MSH-induced ERK1/2 phosphorylation was sensitive to pertussis toxin and the PI3K inhibitor, wortmannin. Rp-cAMPS, BAPTA-AM and Myr-PKC did not inhibit the NDP-MSH-induced ERK1/2 phosphorylation. NDP-MSH stimulated cellular proliferation in a dose-dependent manner with a similar EC(50) to ERK1/2 phosphorylation, 2.1+/-0.6 x 10(-)(9) M. Cellular proliferation was blocked by AGRP (86-132) and by the MEK inhibitor, PD98059. The NDP-MSH did not inhibit serum deprivation-induced apoptosis. MC3R activation induces ERK1/2 phosphorylation via PI3K and this pathway is involved in cellular proliferation in HEK cells expressing MC3R.
Insights
Activation of the melanocortin-3 receptor (MC3R) by NDP-MSH triggers ERK1/2 phosphorylation and cellular proliferation in HEK cells. This process involves phosphoinositide 3-kinase (PI3K) signaling.
Area of Science:
- Cellular and Molecular Biology
- Endocrinology
- Pharmacology
Background:
- The melanocortin-3 receptor (MC3R) is a G protein-coupled receptor involved in various physiological processes.
- Understanding MC3R signaling pathways is crucial for developing targeted therapeutics.
Purpose of the Study:
- To investigate the signaling pathways downstream of MC3R activation.
- To determine the role of MC3R in cellular proliferation and apoptosis.
Main Methods:
- HEK 293 cells stably expressing human MC3R were treated with the MC3R agonist NDP-MSH.
- ERK1/2 phosphorylation, cellular proliferation, and apoptosis were measured.
- Pharmacological inhibitors and antagonists were used to elucidate signaling pathways.
Main Results:
- NDP-MSH induced dose-dependent ERK1/2 phosphorylation (EC50 = 3.3 ± 1.5 x 10⁻⁹ M) and cellular proliferation (EC50 = 2.1 ± 0.6 x 10⁻⁹ M).
- ERK1/2 phosphorylation was sensitive to pertussis toxin and the PI3K inhibitor wortmannin, but not Rp-cAMPS, BAPTA-AM, or Myr-PKC.
- Cellular proliferation was inhibited by AGRP (86-132) and the MEK inhibitor PD98059.
- NDP-MSH did not affect serum deprivation-induced apoptosis.
Conclusions:
- MC3R activation stimulates ERK1/2 phosphorylation through a pathway involving PI3K.
- This PI3K-dependent ERK1/2 phosphorylation pathway mediates cellular proliferation in HEK cells expressing MC3R.
- MC3R activation does not appear to influence apoptosis in this model system.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway
Microtubule Associated Proteins (MAPs)

